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We wish to congratulate Parkes et al. for their interesting
findings on hantavirus pulmonary syndrome (HPS). They
reported about three cases among Canadian military, who
have fallen ill almost simultaneously about one month after
participating in the same grand scale manoeuvres in Alberta,
Canada, spring 2015 [1]. We want to extend their experience
with similar findings, likewise in Canadian and in other
military.
To our knowledge, the first (1988) clinically documented
case of a hantavirus infection in a Canadian was also in the
military, working however as a staff officer in the Supreme
Headquarters of Allied Powers in Europe (SHAPE) in Bel-
gium, and with no known prior history of rodent exposure
[2]. However, he lived in a Belgian forested region highly
endemic for Puumala virus (PUUV), and his IgM and IgG
ELISA titers were highest for CG 13891, a PUUV strain, now
rebaptized as CG Turnhout, and isolated already in 1985
from a bank vole, captured on a military exercise terrain
near Turnhout, inNorth Belgium [3].Moreover, this “SHAPE
case” was later (1990) shown by neutralization testing (NT),
the gold standard for confirming the infecting hantavirus
species, to yield negative results for the prototype Korean
hantavirus Hantaan virus (HTNV) and the worldwide rat-
transmitted Seoul virus (SEOV) but to show titers of 80
for 80% neutralization and of 320 for 50% neutralization of
PUUV (courtesy of James LeDuc, United States Army Med-
ical Research Institute for Infectious Diseases (USAMRIID),
unpublished 1990 NT results, sample Canada December 30,
1988, log # 682). Thus, this pioneer Canadian case was
established to be in fact the first NT-confirmed PUUV
infection in a NewWorld patient.
Of even more interest, this same 1988 case appeared
in retrospect to be one of the very first (and consequently
then ill-understood) so-called “European HPS cases,” that
is, the long-time underevaluated combination of acute lung
injury (ALI) and acute kidney injury (AKI), with rapid
deterioration of both lung and kidney function, necessitating
often an Intensive Care Unit (ICU) admittance, mostly for
acute lung problems. Indeed, he presented with rapidly
worsening dyspnea, evanescent RX bilateral lung infiltrates
suggestive for acute lung edema, and serious oxygen desat-
uration, prompting controlled oxygen and furosemide ICU
therapy [2]. The concomitant distinct AKI needed however
no specific renal replacement therapy (RRT), and both ALI
and AKI resolved spontaneously and typically within two
weeks [2]. Herewith, six years before the description of Sin
Nombre virus- (SNV-) induced HPS as a newly recognized
disease in SouthwesternUSA [4], a very similar entity of acute
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noncardiogenic lung edema, during a hantavirus infection in
a previously healthy young adult, was already reported from
Europe.
Another unusual hantavirus infection occurred also in a
case in the Canadian military, working as a radio operator
in the besieged city of Sarajevo during the Bosnian War [5].
In July 1992, he developed a severe AKI and worsening
dyspnea, for which a helicopter evacuation to the Zagreb
University Hospital was needed. Local Croatian physicians,
although well familiarized with the European hantaviral AKI
form, commonly called “hemorrhagic fever with renal syn-
drome” (HFRS), were puzzled by three consecutive IgG
immunofluorescence assays (IFA), all negative for the then
generally used hantavirus screening antigen, being the pro-
totype Korean HTNV 76-118 strain. In this 1992 Croatian
hospital report, pulmonary complications were not yet
explicit, and finally no RRT was needed. Convalescent serum
revealed in our hands high IgG IFA titers for two SEOV
strains and for a then novel Dobrava virus (DOBV) strain,
whereas IgM ELISA was clearly positive for HTNV 76-11.
In PRNT (plaque-reduction neutralization test), the highest
50% neutralizing titer of 320 was for a SEOV strain (R22VP
30) [5]. Consequently, and particularly with regard to the
patient’s history of high exposure to wild rats, a rare diagnosis
of European SEOV infection was put forward. However,
the then recently isolated DOBV-Af strain could not be
cultured in plaques for completing the battery of viruses for
neutralization testing, leaving some lingering doubts about
the exact origin of hantaviral infection. It became only clear
after one of us (A˚ke Lundkvist, Sweden) had performed
later a broader-spectrum focus-reduction neutralization test
(FRNT) that this Canadian military had been infected in
fact with a DOBV strain, explaining the more severe clinical
course with dyspnea and thus constituting retrospectively
this 1992 Sarajevo case as the first clinically documented and
FRNT-confirmed DOBV case in Europe and the first “HPS”
case caused by DOBV. However, a preliminary prior 1991
screening of mixed civilian and military European “HFRS”
cases with an ELISA format, consisting of HTNV, SEOV,
PUUV, and the then novel DOBV-Af antigen, had yielded
already high titers toDOBV in 14/32 of Slovenian samples and
in 2/27 of Belgian and Dutch samples [6].
Of interest, a very severe and rapid-onset ALI and AKI
case was equally reported during the BosnianWar in a British
soldier, prompting urgent air evacuation to his homeland,
after emergency intubation and ventilation. A seriously
deteriorating pulmonary, cardiac, and renal condition could
be reversed only by a combination of high-tech ICU ven-
tilation treatments in London, but RRT was not needed
[7]. Here again, highest IgM and IgG ELISA titers were
initially found against SEOV, but a later NT determined an
underlying DOBV infection, confirming once again the
severity potential of this hantavirus species (courtesy of
Graham Lloyd, Public Health Laboratory, Porton Down, UK,
unpublished data).
As noted by the current authors [1], a former “normal”
HFRS scenario was demonstrated already in January 1990,
when the first PUUV-induced HFRS outbreak in Germany,
conspicuously enough exclusively in US military, was noted
during NATO winter manoeuvres near Ulm, Baden-
Wu¨rttemberg (South Germany), totalling 15 IgM PUUV-
confirmed and hospitalized AKI cases within 2 weeks [8].
The astonishing attack rate of 8.5% in the most stricken
177-member military logistic unit was in stark contrast with
the fact that, during the entire same 1990 winter period,
no civilian German HFRS (or HPS) case was registered in
the same endemic Ulm region, demonstrating again that an
unusual rodent exposure was and still is the most important
risk factor for human hantavirus infections. Consequently,
for one-month-long manoeuvres in the most endemic
province of Canada, involving 6,750 military personnel
from three different countries (Canada, USA, and UK),
with supposedly the same degree of exposure, we wonder
if the detection and description of a HPS cluster only in
Canadian participants are to be ascribed solely to the clinical
acumen of their compatriot physicians. Since moreover mild
or asymptomatic SNV infections have been described, and
even a rare SEOV-induced classic “HFRS” is not excluded in
the New World (albeit much less frequently so in a forested
biotope) [9], only extensive postmanoeuvre blood sampling
could bring clarification. After the American 1990 PUUV
outbreak in Germany, such an initiative yielded an additional
8 IgM-positive subclinical PUUV infections, whereas an
ensuing US Army case-control study, the first of its kind in
the young hantavirus era, singled out such now generally
accepted risk factors as “sighting rodents” and “sleeping in
hay” [8]. Of note, hantavirus screening for military operating
in the European field should ideally comprise all hitherto
known Old World hantaviral pathogens, being HTNV,
SEOV, PUUV, DOBV, and even Tula virus (TULV), bearing
in mind that all classic serological techniques can suffer from
cross-reactions, including even PUUV cross-reacting with
its American, but genetically related counterparts SNV and
Andes virus (ANDV) [10].
With this brief recent historic overview, it should be clear
that military operations in a European war- or manoeuvre-
theatre enhance the risk for incurring not onlyHFRS, but also
sometimes life-threatening “HPS” symptoms, most notably
in a combination of both. This is an important reminder for
military and even civilian, clinicians, and epidemiologists on
both sides of the Atlantic. Although now a constant mantra
in hantavirus literature since over 20 years [4], it remains a
matter of debate of how two genetically related hantaviruses,
after infection of humans via the same entry port (the
lung) and inducing a pronounced but transient inflammatory
“cytokine storm” with subsequent vascular leak, should
consistently lead to two different clinical syndromes, or at
least two syndromes with different, but often inappropriate,
names, that is, HFRS and/or HPS, mainly because they occur
on two different sides of the Atlantic [9].
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